Literature DB >> 25091709

Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas.

Domenico Genovesi1, Francesca Perrotti, Marianna Trignani, Angelo Di Pilla, Annamaria Vinciguerra, Antonietta Augurio, Monica Di Tommaso, Massimo Caulo, Massimo Savastano, Armando Tartaro, Antonio Raffaele Cotroneo, Giampiero Ausili Cèfaro.   

Abstract

BACKGROUND AND
PURPOSE: Sparing of the organs at risk is one of the primary end-points of radiotherapy. The effects of organ-at-risk delineation on the dosimetric parameters can be critical and can influence treatment planning and outcomes. The aim of our study was to provide anatomical boundaries for the identification and delineation of the following critical organs at risk in the head and neck district: brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm. PATIENTS AND METHODS: One patient was initially selected to elaborate our atlas. This patient was subjected to a planning computed tomography of the brain and head and neck district; axial images of 3-mm thickness at 3-mm intervals were obtained. In the same set-up a magnetic resonance imaging study was also performed. The obtained images were fused based on anatomical landmarks and used by a radiation oncologist, supported by a neuroradiologist, to provide anatomo-radiological limits for the identification of the brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm. These limits were further verified on three consecutive patients.
RESULTS: A computed tomography-based atlas was developed with definition of cranial, caudal, medial, lateral, anterior and posterior limits for each organ considered.
CONCLUSIONS: This study allows improvement of definitions of anatomic boundaries for the brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm. Our multidisciplinary experience led to the production of an institutional reference tool that could represent a useful aid for radiation oncologists in clinical practice.

Entities:  

Mesh:

Year:  2014        PMID: 25091709     DOI: 10.1007/s11547-014-0448-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  39 in total

Review 1.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan.

Authors:  Olivier Chapet; Feng-Ming Kong; Leslie E Quint; Andrew C Chang; Randall K Ten Haken; Avraham Eisbruch; James A Hayman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

3.  Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.

Authors:  Charlie C Pan; Avraham Eisbruch; Julia S Lee; Rhonda M Snorrason; Randall K Ten Haken; Paul R Kileny
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

4.  Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.

Authors:  Henriette B Honoré; Søren M Bentzen; Kitty Møller; Cai Grau
Journal:  Radiother Oncol       Date:  2002-10       Impact factor: 6.280

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 6.  Late effects of radiation on the eye and ocular adnexa.

Authors:  K B Gordon; D H Char; R H Sagerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

7.  Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues.

Authors:  Nam P Nguyen; Sabah Sallah; Ulf Karlsson; John E Antoine
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

8.  Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.

Authors:  Avraham Eisbruch; Hyungjin M Kim; Felix Y Feng; Teresa H Lyden; Marc J Haxer; Mary Feng; Frank P Worden; Carol R Bradford; Mark E Prince; Jeffrey S Moyer; Gregory T Wolf; Douglas B Chepeha; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-17       Impact factor: 7.038

9.  Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.

Authors:  Shreerang A Bhide; Sarah Gulliford; Rehan Kazi; Iman El-Hariry; Kate Newbold; Kevin J Harrington; Christopher M Nutting
Journal:  Radiother Oncol       Date:  2009-10-31       Impact factor: 6.280

10.  Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.

Authors:  Piet Dirix; Sarah Abbeel; Bianca Vanstraelen; Robert Hermans; Sandra Nuyts
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-24       Impact factor: 7.038

View more
  3 in total

1.  Development of a contouring guide in three different head set-ups for hippocampal sparing radiotherapy: a practical approach.

Authors:  Saide Di Biase; Marianna Trignani; Luciana Caravatta; Paul Ioan Voicu; Clelia Di Carlo; Annamaria Vinciguerra; Antonietta Augurio; Francesca Perrotti; Valentina Panara; Domenico Genovesi
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

2.  Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study.

Authors:  L H Braun; K Braun; B Frey; S M Wolpert; H Löwenheim; D Zips; S Welz
Journal:  Strahlenther Onkol       Date:  2018-08-14       Impact factor: 3.621

3.  Interobserver variability in organ at risk delineation in head and neck cancer.

Authors:  J van der Veen; A Gulyban; S Willems; F Maes; S Nuyts
Journal:  Radiat Oncol       Date:  2021-06-28       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.